PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Paracetamol - Pain

PAD Profile : Paracetamol - Pain

Keywords :
Analgesia, analgesics

Traffic Light Status

Status 1 of 4.

Status :
Green
Preferred
Formulations :
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Comments :
No comments returned.
Documents :

Status 2 of 4.

Status :
Green (see narrative)
Important
Formulations :
  • Effervescent tablets
  • Soluble tablets
  • Suppositories
Important Information :
Reserve for patients who cannot swallow solid dose forms. Soluble / effervescent preparations have a high sodium content and more expensive than ordinary tablets. Suppositories for use when oral route is not suitable
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
R
Comments :
No comments returned.
Documents :

Status 3 of 4.

Status :
Green (see narrative)
Important
Formulations :
  • Oral suspension
Important Information :
120mg/5ml and 250mg/5ml reserved for patients who cannot swallow solid dose forms or where sodium content of dispersible preparations is a problem. Non-formulary: Paracetamol oral suspension 500mg/5ml. Much more expensive. Use a soluble formulation.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
R
Comments :
No comments returned.
Documents :

Status 4 of 4.

Status :
Red
Important
Formulations :
  • Intravenous infusion
Important Information :
Prescribe in milligrams for doses <1g. Review infusion prescriptions after 48-72 hours. Note risk of overdose with IV paracetamol.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
SA
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Paracetamol is considered a 1st line option for the treatment option for pain (except diabetic neuropathy), see guidelines below for further information. Please see narrative below for information on paracetamol products:

  • Paracetamol Tablets 500mg: GREEN (1st line treatment option)
  • Paracetamol oral suspension 120mg/5ml, 250mg/5ml - GREEN (1st line treatment option IF suspension is indicated)

Effervescent or soluble formulations: 
There is no advantage in patient who can swallow tablets, these products contain high concentrations of sodium and are expensive. Avoid use unless patient has difficulty swallowing

  • Paracetamol dispersible tablets 500mg - GREEN 

When oral preparations are not appropriate:

  • Paracetamol suppository 60mg, 125mg, 250mg, 500mg - GREEN 

Not recommended for use in any healthcare setting across Surrey CCGs

Paracetamol combination products: 

Associated BNF Codes

04. Central Nervous System
04.07.01. Non-opioid analgesics and compound preparations
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More